Detail Information of Xenobiotics-driven Alterations in 3D Complexes
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0007 Transporter Info | ||||
Gene Name | SLC47A1 | ||||
Transporter Name | Multidrug and toxin extrusion protein 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
Xenobiotic Name | Talipexole Drug Info | ||||
Xenobiotic Type | Drug in Phase 4 Trial | ||||
MOA | Inhibition | ||||
PubChem CID | 5374 | ||||
Docking Score | -6.536 kcal/mol | ||||
EFMDA Details | EFMDA Info | ||||
Xenobiotic Details | |||||
Formula | C10H15N3S | ||||
Molecular Weight | 209.31 | ||||
Canonical SMILES |
C=CCN1CCC2=C(CC1)SC(=N2)N
|
||||
InChI |
InChI=1S/C10H15N3S/c1-2-5-13-6-3-8-9(4-7-13)14-10(11)12-8/h2H,1,3-7H2,(H2,11,12)
|
||||
InChIKey | DHSSDEDRBUKTQY-UHFFFAOYSA-N | ||||
Pharmaceutical Properties | Xlogp | 1.5 | Rotatable Bond Count | 2 | |
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 4 | ||
Xenobiotic Name | Ciclopirox Drug Info | ||||
Xenobiotic Type | Approved Drug | ||||
MOA | Inhibition | ||||
PubChem CID | 2749 | ||||
Docking Score | -6.367 kcal/mol | ||||
EFMDA Details | EFMDA Info | ||||
Xenobiotic Details | |||||
Formula | C12H17NO2 | ||||
Molecular Weight | 207.27 | ||||
Canonical SMILES |
CC1=CC(=O)N(C(=C1)C2CCCCC2)O
|
||||
InChI |
InChI=1S/C12H17NO2/c1-9-7-11(13(15)12(14)8-9)10-5-3-2-4-6-10/h7-8,10,15H,2-6H2,1H3
|
||||
InChIKey | SCKYRAXSEDYPSA-UHFFFAOYSA-N | ||||
Pharmaceutical Properties | Xlogp | 2 | Rotatable Bond Count | 1 | |
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 2 | ||
Xenobiotic Name | Lidocaine Drug Info | ||||
Xenobiotic Type | Approved Drug | ||||
MOA | Inhibition | ||||
PubChem CID | 3676 | ||||
Docking Score | -6.351 kcal/mol | ||||
EFMDA Details | EFMDA Info | ||||
Xenobiotic Details | |||||
Formula | C14H22N2O | ||||
Molecular Weight | 234.34 | ||||
Canonical SMILES |
CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
|
||||
InChI |
InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)
|
||||
InChIKey | NNJVILVZKWQKPM-UHFFFAOYSA-N | ||||
Pharmaceutical Properties | Xlogp | 2.3 | Rotatable Bond Count | 5 | |
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 2 | ||
Pagination
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.